| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Deferred consideration paid in connection with evoqua asset acquisition | 1,621 | 871 |
| Net cash provided by financing activities | 5,311 | -1,433 |
| Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
| Net (decrease) increase in cash and cash equivalents | -2,052 | -3,180 |
| Cash and cash equivalents at beginning of period | 15,662 | - |
| Cash and cash equivalents at end of period | 13,610 | - |
ROCKWELL MEDICAL, INC. (RMTI)
ROCKWELL MEDICAL, INC. (RMTI)